Sigba, Leah .
HRN: 26-78-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2025
METRONIDAZOLE 500MG (TAB)
03/09/2025
03/15/2025
PO
1 Tab
TID
Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes